Microbial genomics is revolutionizing our understanding of probiotics and their benefits. By sequencing the genomes of beneficial bacteria, researchers can gain insights into their genetic makeup, metabolic capabilities, and interactions with the host. This detailed genetic information allows for the identification of specific probiotic strains that offer targeted health benefits, such as enhanced immune support or improved digestion. Additionally, microbial genomics helps in understanding how probiotics metabolize prebiotics—non-digestible fibers that serve as their food. This knowledge facilitates the development of more effective probiotic formulations and dietary recommendations. As a result, microbial genomics not only advances our comprehension of how probiotics and prebiotics work together but also contributes to the creation of personalized and more effective health interventions.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India